GSK to quit London HQ as healthcare giant pushes ahead with split | Evening Standard
GlaxoSmithKline becomes GSK
What's in store for GSK after its Haleon split next week?
GSK Stock: A Defensive With A Healthy Dividend Yield | Seeking Alpha
GlaxoSmithKline ingresó 16.709 millones de euros hasta ju...
GSK consumer healthcare division in talks with investment banks to advise (NYSE:GSK) | Seeking Alpha
GlaxoSmithKline (GSK) HQ, Great West Road, Brentford, Hounslow, London Borough of Greater London, England, Reino Unido Fotografía de stock - Alamy
GSK plc - Wikipedia
Analysts say GSK is right to rebuff £50bn offer for consumer healthcare venture | GlaxoSmithKline | The Guardian
GSK refuerza su negocio de cáncer pagando 1.750 millones por Sierra Oncology | Empresas | Cinco Días
Is GSK A Good Choice For Dividend Investors? | Seeking Alpha
GSK Share Forecast, Price & News (LON:GSK)
Can GSK shares see a post-earnings spike after Haleon spinoff? | Opto
Detalle exterior de la sede mundial de la compañía farmacéutica gsk, glaxosmithkline, mostrando el logotipo de la empresa, con sede en Londres, Inglaterra Fotografía de stock - Alamy
GSK's consumer arm Haleon debuts with lackluster valuation
GSK (LON:GSK) full-year results: where next for the share price? | IG UK
GSK reports £8.1 billion in Q2 sales - European Pharmaceutical Review
Glaxo Smith Kline GSK Edificio Great West Road, London Fotografía de stock - Alamy
La sede mundial de la compañía farmacéutica Glaxo Smith Kline, GSK, Brentford, Londres, Inglaterra Fotografía de stock - Alamy
GSK takes a cue from Sanofi with plans for a new headquarters
Calculating The Intrinsic Value Of GlaxoSmithKline plc (LON:GSK)
GSK: Near-Term Upside (OTCMKTS:GLAXF) | Seeking Alpha
GlaxoSmithKline Stock Forecast | Is GlaxoSmithKline a Good Stock to Buy?
GSK traslada su sede mundial al centro de Londres | PlantaDoce
GlaxoSmithKline (LON:GSK) share price: what to expect from its Q1 results | IG UK
Bellus' stock surges as GSK coughs up $2B for an acquisition | BioWorld
Ligand Pharma, GSK expand existing license deal | Seeking Alpha
